B2M and neoplasm: The functionality of NK cells from Nlrc5−/− and CD4cre Nlrc5fl/fl mice was then assessed by testing the ability to reject B2m−/− splenocytes (Fig. 3a) or MHCI-negative RMA-S tumour cells (Fig. 3b).